Guardant Health (GH) Tops Q2 EPS by 21c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/30/2026

1. INTC
2. AMZN
3. PINS
4. COIN
5. RDDT
6. FSLR
7. SYK
8. MA
9. FND
10. DASH

Go back to Guardant Health (GH) Tops Q2 EPS by 21c

Guardant Health Reports Second Quarter 2022 Financial Results

August 4, 2022 4:05 PM EDT

Q2 clinical and biopharma volumes up 40% and 65% year over year

PALO ALTO, Calif.--(BUSINESS WIRE)-- Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary tests, vast data sets and advanced analytics, today reported financial results for the quarter ended June 30, 2022.

Recent Highlights

Revenue of $109.1 million for the second quarter of 2022, an increase of 19% over the corresponding period of 2021 Reported 29,300 tests to clinical customers and 6,000 tests to biopharmaceutical customers in the second... More